Shares in Indian drugmakers fall, with Dr Reddys Laboratories down 1.9 per cent, on concerns that sales in Russia and Ukraine will be hit given military tensions between the two countries.
Dr. Reddy’s has the highest exposure to Russia and former Soviet republics, with the region comprising 14.5 percent of sales, Bank of America-Merrill Lynch says in a note dated on Monday.
Shares in Glenmark fall 1.11 percent, while Ranbaxy is down 1.86 percent at 0411 GMT.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines